SCHEMBL440641

SCHEMBL440641

C=C(C#N)C(=O)OC(CC)OC

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
TSHR P16473 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292579 0.92 ALDH1A1 (0.67) ALDH1A1TSHR
SCHEMBL28362672 0.92 ALDH1A1 (0.47) ALDH1A1TSHR
SCHEMBL2675454 0.86 ALDH1A1 (0.49) ALDH1A1TSHR
SCHEMBL4885635 0.84 ALDH1A1 (0.44) ALDH1A1TSHR
SCHEMBL4888140 0.84 ALDH1A1 (0.55) ALDH1A1TSHR
SCHEMBL20472549 0.83 TSHR (0.46) ALDH1A1TSHR
SCHEMBL4890624 0.83 ALDH1A1 (0.42) ALDH1A1TSHR
SCHEMBL28683384 0.83 ALDH1A1 (0.49) ALDH1A1TSHR
SCHEMBL4891423 0.82 ALDH1A1 (0.45) ALDH1A1TSHR
SCHEMBL4892558 0.81 ALDH1A1 (0.47) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606719-B2 Methods and compositions comprising biodegradable cyanoacrylates FEMASYS INC. (US) 2026-04-21 US claimed
US-20260062590-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS FEMASYS INC (US) 2026-03-05 US claimed
EP-4613213-A2 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS Femasys, Inc. (US) 2025-09-10 EP claimed
EP-3579890-B1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FEMASYS INC (US) 2025-06-18 EP claimed
US-20230390105-A1 METHODS AND DEVICES FOR CONTROLLED DELIVERY POINTILLIST GLOBAL MACRO SERIES OF POINTILLIST PARTNERS LLC 2023-12-07 US claimed
US-20230364304-A1 METHODS OF FORMING BONE INTERFACE SCAFFOLDS Sparta Biopharma LLC (US) 2023-11-16 US claimed
CN-115627124-A Low-whitening impact-resistant quick-drying adhesive composition and preparation method thereof 上海兰盛新材料科技有限公司 2023-01-20 CN claimed
US-11364324-B2 Methods of forming bone interface scaffolds SPARTA BIOPHARMA INC. (US) 2022-06-21 US claimed
US-20220054709-A1 METHODS OF FORMING BONE INTERFACE SCAFFOLDS SPARTA BIOPHARMA INC. 2022-02-24 US claimed
CN-113631676-A Cyanoacrylate adhesive compositions 汉高股份有限及两合公司 2021-11-09 CN claimed
WO-2006034157-A2 PACKAGE COMPONENTS FOR RADIOCHEMICAL STERILIZATION POLY-MED, INC. (US) 2006-03-30 WO claimed
EP-0952171-B1 Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof POLY MED INC (US) 2006-01-04 EP claimed
US-20050042197-A1 Stabilized polyester/cyanoacrylate tissue adhesive formulation POLY-MED, INC. 2005-02-24 US claimed
US-20040199207-A1 Polyester/cyanoacrylate tissue adhesive compositions POLY-MED, INC. 2004-10-07 US claimed
US-6699940-B2 Cyanoacrylate-capped heterochain polymers and tissue adhesives and sealants therefrom POLY MED, INC. 2004-03-02 US claimed
US-6632450-B1 Adherable biomaterial patches and methods for producing and for using same Gregory, Kenton 2003-10-14 US claimed
US-20030105256-A1 Cyanoacrylate-capped heterochain polymers and tissue adhesives and sealants therefrom POLY-MED, INC. 2003-06-05 US claimed
US-20030069535-A1 Stabilized polyester/cyanoacrylate tissue adhesive formulation POLY-MED, INC. 2003-04-10 US claimed
US-6413539-B1 BLOCK POLYMER POLY-MED, INC. 2002-07-02 US claimed
EP-0952171-A2 Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof Poly-Med Inc. (US) 1999-10-27 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062590-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS PGF, ACR, FGB ALDH1A1 247/4885TSHR 2244/4885
US-12606719-B2 Methods and compositions comprising biodegradable cyanoacrylates MKI67, ACR, PGF ALDH1A1 159/4885TSHR 3297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.